Not bashing, just being realistic. The point is, if they were doing all 5 implants nearly simultaneously, the failure of one would not halt trials, barring a catastrophe. Let's say though that 3 of 5 would be succesful. That's still a great improvement from current nonexistent treatments and reason to continue development.
However, if the first implant is one of the two unsuccessful ones of five, it's possible that would effectively end all trials.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.